UK pharma firm Clinigen opens Japan office to boost Asia presence

UK pharma firm Clinigen opens Japan office to boost Asia presence

UK pharma firm Clinigen Group plc has opened an office in Tokyo and set up Clinigen KK, a move to strengthen its presence in Asia after the acquisition of Asia and Africa focused pharma firm Link Healthcare last year.

Announcing the launch of its business in Japan in a statement today, Clinigen said that alongside the launch, Clinigen KK will transfer the marketing authorisation for its lead Specialty Pharmaceutical (SP) product Foscavir® (foscarnet sodium) back from its Japanese distribution partner Nobel Pharma on November 1.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter